Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take Newsletter

FDA approves first treatment targeting muscle loss in spinal muscular atrophy

Read Now

News and Insights

Showing items 1 to3 of 6

Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results 1

Date
Lilly’s ‘triple G’ candidate exceeds analysts’ expectations
Insight
Our Take Newsletter
January 14, 2026

Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Learn More
January 14, 2026
Pharma strategy, engagement, and market access
Eli Lilly achieves market value of $1 trillion
Insight
Our Take Newsletter
December 8, 2025

Eli Lilly achieves market value of $1 trillion

Learn More
December 8, 2025
Pharma strategy, engagement, and market access
Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences
Insight
Our Take Newsletter
November 24, 2025

Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences

Learn More
November 24, 2025
IDN trends, challenges, and leadership
CMS launches payment model to lower Medicaid drug spending
Insight
Our Take Newsletter
November 17, 2025

CMS launches payment model to lower Medicaid drug spending

Learn More
November 17, 2025
Health policy, CMS initiatives and health economics
Pfizer wins bidding war to acquire Metsera
Insight
Our Take Newsletter
November 10, 2025

Pfizer wins bidding war to acquire Metsera

Learn More
November 10, 2025
Pharma strategy, engagement, and market access
PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs
Insight
Our Take Newsletter
November 3, 2025

PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs

Learn More
November 3, 2025
Pharmacy, PBMs and drug pricing
An uptick in health system collaborations and affiliations
Insight
Our Take Newsletter
October 27, 2025

An uptick in health system collaborations and affiliations

Learn More
October 27, 2025
IDN trends, challenges, and leadership
Amazon to offer pharmacy kiosks at One Medical clinics
Insight
Our Take Newsletter
October 13, 2025

Amazon to offer pharmacy kiosks at One Medical clinics

Learn More
October 13, 2025
Pharmacy, PBMs and drug pricing
New California laws take aim at PBMs and more
Insight
Our Take Newsletter
October 20, 2025

New California laws take aim at PBMs and more

Learn More
October 20, 2025
Pharmacy, PBMs and drug pricing
Notable recent transactions among Big Pharma and life sciences companies
Insight
Our Take Newsletter
September 22, 2025

Notable recent transactions among Big Pharma and life sciences companies

Learn More
September 22, 2025
Pharma strategy, engagement, and market access
Genmab agrees to acquire Dutch biotech Merus for $8 billion
Insight
Our Take Newsletter
October 6, 2025

Genmab agrees to acquire Dutch biotech Merus for $8 billion

Learn More
October 6, 2025
IDN trends, challenges, and leadership
GAO report on physician consolidation
Insight
Our Take Newsletter
September 29, 2025

GAO report on physician consolidation

Learn More
September 29, 2025
IDN trends, challenges, and leadership
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.